Effects of nanoliposomal irinotecan (nal-IRI;MM-398) 5-Fluorouracil and leucavorin (5-FU/LV) on quality of life (QoL) in NAPOLI-1: a phase 3 study in patients (pts) with metastatic pancreatic adenocarcinoma (mPAC) previously treated with gemcitabine-based therapy.
Authors
Siveke, JCubillo, A
Blanc, J
Melisi, D
Von Hoff, D
Wang-Gillam, A
Chen, L
Becker, C
Mamlouk, K
Belanger, B
Yang, Y
de Jong, F
Hubner, Richard A
Affiliation
West German Cancer Centre, University Hospital Essen, Essen, GermanyIssue Date
2016